An Open-Label Multicenter Phase 1b Study of E7046 in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Subjects With Rectum Cancer

Trial Profile

An Open-Label Multicenter Phase 1b Study of E7046 in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Subjects With Rectum Cancer

Recruiting
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs E 7046 (Primary)
  • Indications Rectal cancer
  • Focus Adverse reactions
  • Acronyms PRAER 1
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 14 Aug 2017 Planned End Date changed from 1 Nov 2019 to 1 Jan 2019.
    • 14 Aug 2017 Planned primary completion date changed from 1 Jan 2019 to 1 Apr 2018.
    • 14 Aug 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top